设为首页 加入收藏

TOP

肝新药Viekira+Exviera已获欧盟批准用于治疗慢性丙型肝炎(四)
2017-03-20 13:44:12 来源: 作者: 【 】 浏览:2188次 评论:0
their metabolites are excreted in human breast milk.
SIDE EFFECTS: See SmPC for full details on side effects. Side-effects identified with Viekirax in combination with Exviera Common side effects (≥1/100 to <1/10): pruritus Side-effects identified with Viekirax in combination with Exviera and ribavirin Very common side effects (≥1/10):insomnia, nausea, pruritus, asthenia and fatigue. Common side effects (≥1/100 to <1/10):anaemia.
LEGAL CATEGORY: POM
MARKETING AUTHORISATION NUMBERS/PRESENTATIONS/BASIC NHS COST: Viekirax 12.5mg/75 mg/50 mg film-coated tablets; daily blister packs containing 2 film-coated tablets, inner cartons containing 14 film-coated tablets in multipack presentation containing 56 (4 packs of 14) film-coated tablets. EU/1/14/982/001 £10,733.33 Exviera 250 mg film-coated tablets; daily blister packs containing 2 film-coated tablets, inner cartons containing 14 film-coated tablets in multipack presentation containing 56 (4 packs of 14) film-coated tablets.
EU/1/14/983/001
MARKETING AUTHORISATION HOLDER: AbbVie Ltd, Maidenhead, SL6 4XE
DATE OF REVISION: January 2015 

Tags: 责任编辑:admin
首页 上一页 1 2 3 4 下一页 尾页 4/4/4
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Actelion局部用氮芥凝胶Ledaga获.. 下一篇Ultresa和Viokace胰脂肪酶胶囊获F..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位